Financial Skeptic (Free subscription) | 07/10/2008
Carl Icahn has announced the United Shareholders of America (USA): The Icahn Plan. Just a few weeks short of the presidential elections and most likelyanticipating a new regulatory regime in financial services Carl Icahn is aggregating voices and hoping to create additional influence. His comments are usually well respected but he has a habit of making big complaints, getting onto...
Denver Post (Free subscription) | 07/10/2008
Billionaire Carl Icahn said he was "cautious on the market" and holding "lots of cash" because of the market turmoil that sent the Dow Jones industrial average below 10,000 on Monday. He said bank debt may be a sound investment.
24/7 Wall St. (Free subscription) | 06/10/2008
Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders. The biotech stock is trading up on a very weak trading day after... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Fat Pitch Financials (Free subscription) | 06/10/2008
Carl Icahn just joined us at the Value Investing Congress. He’s speaking on the current financial crisis and the role of shareholder activism. According to Icahn, the real problems with these financial companies are the Boards. The Boards do not in any way hold managements accountable. They take risks when they shouldn’t. When Boards work they [...]
The Industry Standard (Free subscription) | 06/10/2008
Yahoo's outlook has gone from bad to worse in the past week. Google announced that the ad deal the company had made with Yahoo is on hold pending regulatory investigation , and the company's stock stuttered to a 52-week low, dropping below $15 per share today before rebounding slightly. Perhaps the company would be in better shape had it listened to vocal shareholder Carl Icahn, who may have...
Business Pundit (Free subscription) | 06/10/2008
Someone needs to make a movie about Carl Icahn. The all-star corporate raider is at it again. Icahn, who chairs the notorious pharmaceutical company ImClone’s board, has accepted a $70/share buyout of the company. From Reuters: Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, potentially bringing to a close one [...]
Market Watch (Free subscription) | 06/10/2008
NEW YORK (MarketWatch) - Billionaire investor Carl Icahn said Monday that he is launching a lobbying group named United Shareholders to push legislators to pass more investor-friendly laws.
Forbes (Free subscription) | 06/10/2008
Carl Icahn sells ImClone to Eli Lilly for $7 a share more than Bristol was offering.
DealBook (Free subscription) | yesterday
The list of doubters about Eli Lilly’s $6.5 billion deal to buy ImClone Systems, the biotechnology company controlled by Carl C. Icahn, is growing. When Eli Lilly announced the $70-per-share deal Monday, some analysts questioned the price tag, wondering if the pharmaceutical giant hadn’t overpaid to beat out an offer of $62 a share from Bristol-Myers [...]
Silicon Alley Insider (Free subscription) | 09/10/2008
We got a tip yesterday that bludgeoned Carl Icahn was orchestrating a Yahoo palace coup. We haven't been able to confirm and assume it's hogwash, but at this point we imagine Jerry might even go willingly, just to let someone else take the drubbing for a while. A source did suggest that Yahoo is now hastily revising its mass-firing plan, upping the number of employees who will be shown the...
Contrarian Value Investing (Free subscription) | 09/10/2008
... of it) and would this give the stock price a boost. That boost came when the infamous Carl Icahn jumped on board and the stock hit $30 as many funds thought the deal with Microsoft might go through now that icahn is on board. Management gets greedy and wants a higher bid from Microsoft in hopes of starting a bidding war. Microsoft holds its grounds (ok they gave ground once) and soon...
WebPro News (Free subscription) | yesterday
... Yahoo countered at $37, and Microsoft canceled the whole thing. Not without some drama from Daddy Icahn, who was poised to stage a shotgun wedding until Yahoo somehow sweet-talked him out of it. Yang and Bostock would live to see another day of independence. But this¸ this just makes them look like fools. It’s $12.45 currently. Microsoft’s offer made it $33 just eight months ago. It’s no...
DealBook (Free subscription) | 07/10/2008
Eli Lilly agreed on Monday to pay $6.5 billion to acquire ImClone Systems, the biotechnology company that is controlled by Carl C. Icahn and whose stock was involved in the insider trading scandal that sent Martha Stewart to jail. The deal by Lilly, worth $70 a share, beat out an offer of $62 a share from [...]
Slate Magazine (Free subscription) | 07/10/2008
Last spring, Yahoo was under assault. Microsoft had launched a hostile takeover, activist investor Carl Icahn was promising to sweep out the company's recalcitrant management team, and large shareholders were filing a barrage of lawsuits accusing the company of acting irresponsibly in turning Microsoft away. Yahoo had only one option: run to Google. The search giant offered Yahoo a Faustian...
News & Observer (Free subscription) | 07/10/2008
Eli Lilly & Co.'s winning bid of $6 billion for cancer drugmaker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers and vindication for corporate raider and ImClone Chairman Carl Icahn.
